Tradestie Institutional Equity Comparison Engine

RADX vs PLRZ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PLRZ Overall Edge

PLRZ Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Polyrizon Ltd. Ordinary Shares (PLRZ) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, RADX trades at N/M Forward P/E with -411.6% operating margin (-36.9% YoY revenue) versus PLRZ at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLRZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RADX N/M vs PLRZ N/M Fwd P/E
Growth & Margin Winner PLRZ
Op Margin -411.6% vs 0.0% ยท YoY -36.9% vs +0.0%
Momentum & Technical Winner PLRZ
1Y -86.0% vs +1226.8% ยท 52W Pos 0% vs 50%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RADX NASDAQ
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
$0.63
-6.33% 1D
Market Cap $10.6M
1M Return -33.64%
1Y Return -86.04%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
PLRZ NASDAQ
Polyrizon Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$9.31
-8.42% 1D
Market Cap $24.7M
1M Return +6.76%
1Y Return +1226.78%
Forward P/E N/M
Unified AI Score
31.2 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RADX -86.04% PLRZ +1226.78% Spread: +1313.13 pp (PLRZ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RADX TTM Op. Margin: -411.6% PLRZ TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RADX vs PLRZ. Trailing 12-month operating profitability (RADX -411.6% vs PLRZ 0.0%) and valuation multiples (RADX N/M vs PLRZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RADX (1) vs PLRZ (6)
Institutional Metric RADX PLRZ Criterion Row Winner
Market Capitalization Scale $10.6M $24.7M Larger Scale PLRZ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -36.9% +0.0% Higher Growth PLRZ
Operating Margin (TTM) Profitability -411.6% 0.0% Higher Margin PLRZ
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -174.7% -21.4% Higher ROE PLRZ
52-Week Range Position Momentum 0% ($1โ€“$16) 50% ($0โ€“$18) Stronger Trend PLRZ
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 109% Vol 0.28ฮฒ ยท 86% Vol Lower Realized Risk PLRZ
Unified Institutional Score Composite Signal 41.1 / 100 (SELL) 31.2 / 100 (SELL) Higher Composite RADX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RADX vs PLRZ Buy Guide
RADX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RADX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLRZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLRZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RADX nor PLRZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.